Why spend $750 a dose for a drug you can get for $1?
Imprimis CEO says his drug-compounding strategy is the antidote to ever-escalating pharmaceutical prices
Imprimis CEO says his drug-compounding strategy is the antidote to ever-escalating pharmaceutical prices